EUVIMEDEUVIMED entdecken
Open Access

Acute sleep loss decreases CSF‐to‐blood clearance of Alzheimer's disease biomarkers

Haiyan Liu, Nicolas R Barthélemy, Vitaliy Ovod, James G Bollinger, Yingxin He, Samir L Chahin, Brendan Androff, Randall J Bateman, Brendan P Lucey

Alzheimer's & Dementia · 2023-07 · 19 (7) · 3055-3064

DOI: 10.1002/alz.12930 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 25.01.2023. Verfasst von Haiyan Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Sleep Initiation and Maintenance Disorders, Sleep Wake Disorders. Die Arbeit wurde bisher 90-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NINDS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Sleep deprivation increases cerebrospinal fluid (CSF) amyloid beta (Aβ) and tau levels; however, sleep's effect on Aβ and tau in plasma is unknown.

Methods

In a cross‐over design, CSF Aβ and tau concentrations were measured in five cognitively normal individuals who had blood and CSF collected every 2 hours for 36 hours during sleep‐deprived and normal sleep control conditions.

Results

Aβ40, Aβ42, unphosphorylated tau threonine181 (T181), unphosphorylated tau threonine‐217 (T217), and phosphorylated T181 (pT181) concentrations increased ∼35% to 55% in CSF and decreased ∼5% to 15% in plasma during sleep deprivation. CSF/plasma ratios of all Alzheimer's disease (AD) biomarkers increased during sleep deprivation while the CSF/plasma albumin ratio, a measure of blood–CSF barrier permeability, decreased. CSF and plasma Aβ42/40, pT181/T181, and pT181/Aβ42 ratios were stable longitudinally in both groups.

Discussion

These findings show that sleep loss alters some plasma AD biomarkers by lowering brain clearance mechanisms and needs to be taken into account when interpreting individual plasma AD biomarkers but not ratios.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseSleep Initiation and Maintenance DisordersSleep Wake DisordersHumansAmyloid beta-PeptidesSleep Deprivationtau ProteinsSleepBiomarkersPeptide Fragments

Stichwörter der Autor:innen

Alzheimer's diseasebiomarkerssleep

Substanzen

Amyloid beta-Peptidestau ProteinsBiomarkersPeptide Fragments

Autor:innen und Institutionen

  • Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Tracy Family SILQ Center, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Center on Biological Rhythms and Sleep, Washington University School of Medicine, St. Louis, Missouri, USA.

Förderung

  • NIA NIH HHS
  • NINDS NIH HHS
  • National Institutes of Health
  • National Institute on Aging
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Liu, H., Barthélemy, N. R., Ovod, V., Bollinger, J. G., He, Y., Chahin, S. L., Androff, B., Bateman, R. J., & Lucey, B. P. (2023). Acute sleep loss decreases CSF‐to‐blood clearance of Alzheimer's disease biomarkers. Alzheimer's & Dementia, 19(7), 3055-3064. https://doi.org/10.1002/alz.12930

Vancouver

Liu H, Barthélemy NR, Ovod V, Bollinger JG, He Y, Chahin SL, et al. Acute sleep loss decreases CSF‐to‐blood clearance of Alzheimer's disease biomarkers. Alzheimer's & Dementia. 2023;19(7):3055-3064. doi:10.1002/alz.12930

BibTeX
@article{Liu2023,
  author = {Liu, Haiyan and Barthélemy, Nicolas R and Ovod, Vitaliy and Bollinger, James G and He, Yingxin and Chahin, Samir L and Androff, Brendan and Bateman, Randall J and Lucey, Brendan P},
  title = {Acute sleep loss decreases CSF‐to‐blood clearance of Alzheimer's disease biomarkers},
  journal = {Alzheimer's & Dementia},
  year = {2023},
  volume = {19},
  number = {7},
  pages = {3055--3064},
  doi = {10.1002/alz.12930}
}
Kostenlos starten →